BioNTech Investor Day Presentation Deck

The time is now to facilitate access to mRNA In a connected world, a global approach is required to address public health issues NUM mRNA is a versatile drug class to potentially develop various vaccines A Technology, automation and digitalization allow for new solutions Learnings from the COVID-19 pandemic BIONTECH & The pandemic has shown the power of collaboration and joint efforts

View entire presentation